Fluoroquinolone Restriction as an Effective Antimicrobial Stewardship Intervention

Area of Science:

• Infectious Diseases
• Pharmacology
• Public Health

Background:

• Fluoroquinolones are widely prescribed antibiotics.
• Concerns exist regarding adverse drug events, C. difficile infections, and antibiotic resistance associated with fluoroquinolone use.

Purpose of the Study:

• To review the evidence supporting fluoroquinolone restriction policies in acute care settings.
• To examine the impact of these policies on C. difficile infection rates and the development of antibiotic resistance.

Main Methods:

• Review of existing literature on fluoroquinolone restriction policies.
• Analysis of data on antimicrobial stewardship program interventions.

Main Results:

• Fluoroquinolone restriction policies in hospitals show benefits, including reduced C. difficile infections and ESBL-producing Enterobacteriaceae.
• Blanket restriction policies may be insufficient without complementary antimicrobial stewardship interventions.

Conclusions:

• Formulary restriction of fluoroquinolones in acute care settings is supported by evidence for reducing C. difficile infections and resistance.
• Further research is needed on optimal implementation strategies and use outside acute care settings.